Related Experiment Video
Updated: Dec 19, 2025

Formulation and Characterization of Bioactive Agent Containing Nanodisks
Published on: March 17, 2023
Construction and characterization of avermectin B2 solid nanodispersion
Bo Cui1, Fei Gao1, Zhanghua Zeng1
1Institute of Environment and Sustainable Development in Agriculture, Chinese Academy of Agricultural Sciences, Beijing, 100081, China.
Abstract:
Poorly water-soluble pesticide compounds are difficult to be formulated as environmentally friendly formulations with high efficacy. For the conventional formulations, more than 50% of pesticides are lost during application due to the decomposition of active ingredient, dust drift and running off. Therefore, there is an urgent need to construct a novel formulation for improving the bioavailability of pesticides. The avermectin B2 solid nanodispersion was developed by self-emulsifying and solidification technology. The average particle size, surface tension and contact angle on cabbage leaves of the solid nanodispersion were 35.3 nm, 36.6 mN/m and 58°, respectively. The toxicities of the nanoformulation against diamondback moths and root-knot nematode were more than 1.7 times that of conventional emulsion in water and water dispersible granule. This investigation demonstrated that for foliage-applied pesticides, the formulation bioavailability had positive correlation with wettability which was negatively correlated with surface tension and contact angle. This study provides an easy and scalable technique to construct the effective and environmentally friendly nanoformulations. The toxicity improvement of the solid nanodispersion will significantly reduce dosage and environmental pollution of pesticide. The clarified relationship between formulation parameters and biological activity will contribute to the design and construction of novel pesticide formulations.
Related Concept Videos
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Bioavailability Enhancement: Drug Solubility Enhancement
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

